Gartner® Predicts Augmented Analytics Will Have a Major Impact on Life Sciences Commercial Functions
Gartner® recognizes WhizAI as a Sample Vendor for Augmented Analytics, an emerging technology poised to revolutionize how commercial teams use data insights to optimize outcomes.
Gartner points out that life sciences organizations have reached a turning point. Moving forward, commercial teams must expand and adapt their capabilities to accommodate healthcare providers' expectations for personalized experiences and digital information delivery. Life sciences companies must also equip their market access and patient engagement teams to deliver value and improve patient outcomes. Each of these objectives depends on data-driven decision-making.
Augmented analytics, which Gartner® categorizes on its 2023 Hype Cycle™ as an emerging technology, is crucial in enabling commercial teams to reach those goals.
Download this report to learn about:
- Benefits of augmented analytics for the life sciences commercial function
- Where augmented analytics is on the 2023 life sciences commercial function Hype Cycle™
- How WhizAI is already providing value to its customers today
Contact us to learn more about our data analytics AI platform.
.avif)
.avif)
.avif)
.png)
